The Jupiter Trial:

Justification for the Use of Statins in Prevention: and Intervention Trial Evaluating Rosuvastatin.

Mary Honkanen, MD, ABCL, FAHA - A summary, study details, criteria, lab values, outcomes, events and discussion.

Brief trial summary overview

Additional study details

NEJM Jupiter Trial abstract – “Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein”

 

©2006 Cardiology Associates  |  6701 Airport Blvd., Suite D-330   |  Mobile, AL 36608  |  (251) 607-9797  |  (800) 842-4009
Privacy Policy   |   For website related problems contact webmaster  |  Click the logo to return to the Home page